StockData

Exicure, Inc. (XCUR) stock

XCURNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$1.04−0.04 (-3.70%)

Close on Nov 18, 2026Market cap $6.81MP/E –Yield –

Exicure pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Exicure's pe ratio was 1.6× on Jan 31, 2024.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Jan 31, 20241.6×−0.1
2023Dec 29, 20231.7×–

More Exicure figures

See a number that looks wrong?